Shifts in global health leadership, climate change, and the rise of artificial intelligence (AI) in healthcare are expected to dominate the international health agenda in 2026, experts say. Funding constraints, workforce shortages, and emerging threats will shape policy decisions and determine how countries respond to ongoing and future crises.
Last year, U.S. cuts to humanitarian and development aid sent shockwaves through global health programs. Other countries have since scaled back funding, creating uncertainty for initiatives aimed at preventing disease and supporting vulnerable populations. Anja Langenbucher, Europe office director at the Gates Foundation, said these pauses could slow progress and have lingering effects, particularly as child mortality rates rise for the first time this century.
Despite these challenges, Langenbucher highlighted reasons for cautious optimism. AI-driven tools, next-generation vaccines, and climate-smart agriculture could strengthen resilience and efficiency in healthcare delivery. She noted that stable funding platforms, particularly in the European Union, could help turn long-term possibilities into practical solutions.
The Global Fund to Fight AIDS, Tuberculosis and Malaria pointed to malaria as a priority for 2026. Stalled progress in malaria control and growing drug resistance illustrate the consequences of underfunded and fragmented health systems, including prevention, primary care, and community delivery networks. A spokesperson said the year ahead would be defined by “hard choices,” but also an opportunity to refocus on impact, integration, and national leadership.
Technological innovation is expected to be a key driver of change. AI applications could ease the workload of healthcare professionals, enabling clinicians to dedicate more time to patient care. Philips, a global health technology company, said AI can enhance efficiency and improve decision-making in increasingly complex systems. Biotechnology is also gaining prominence, particularly in Europe, where the new EU Biotech Act is set to influence policy. HIPRA, a Spanish biotech firm, emphasized that advances in diagnostics, vaccines, and medical countermeasures are crucial for pandemic preparedness and national security.
Healthcare systems face additional pressure from workforce shortages, rising demand, ageing populations, and declining mental health among staff. Katherine de Bienassis, a health policy analyst at the OECD, said shortages of nurses, physicians, and specialists reduce system capacity and worsen inequities. Policymakers are likely to focus on improving productivity while maintaining care quality.
Climate change will introduce new health risks, including faster spread of vector-borne diseases, pollution-related illnesses, and biodiversity loss. Génon K. Jensen of the Health and Environment Alliance urged that climate adaptation policies prioritize health, including nature-based solutions to prevent disease and enhance resilience.
Pharmaceutical competitiveness, gender health gaps, sexually transmitted infections, and antimicrobial resistance are also expected to shape global health discussions. Experts warn that continued cross-border collaboration, strategic investment, and political commitment will be critical to prevent another year of “neglect” in global health priorities.
